(Q53252179)

12 May 2018

title

Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells. (English)

1 reference

12 May 2018

author

Yu-Jia Chang

12

1 reference

12 May 2018

author name string

Cheng-Jeng Tai

1

1 reference

12 May 2018

Hung Chin-Sheng

2

1 reference

12 May 2018

Li-Jen Kuo

3

1 reference

12 May 2018

Po-Li Wei

4

1 reference

12 May 2018

Hsuan-Hsuan Lu

5

1 reference

12 May 2018

Hsin-An Chen

6

1 reference

12 May 2018

Tsan-Zon Liu

7

1 reference

12 May 2018

Jun-Jen Liu

8

1 reference

12 May 2018

Der-Zen Liu

9

1 reference

12 May 2018

Yuan-Soon Ho

10

1 reference

12 May 2018

Chih-Hsiung Wu

11

1 reference

12 May 2018

publication date

23 April 2011

1 reference

12 May 2018

Annals of Surgical Oncology

published in

1 reference

12 May 2018

volume

19

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

336-343

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1245/s10434-011-1692-5

exact match

0 references

cites work

IAPs: what's in a name?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Survivin, cancer networks and pathway-directed drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Targeted therapy by disabling crossroad signaling networks: the survivin paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Pleiotropic cell-division defects and apoptosis induced by interference with survivin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Survivin promotes cell proliferation in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

The cause of infant and toddler subdural hemorrhage: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

EMT, the cytoskeleton, and cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Survivin as a global target of intrinsic tumor suppression networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Roles of GRP78 in physiology and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Targeting the unfolded protein response in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Overcoming drug resistance by enhancing apoptosis of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Antisense oligonucleotides targeting midkine induced apoptosis and increased chemosensitivity in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

Epidemiology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1692-5

10.1245/S10434-011-1692-5

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

Dimensions Publication ID

1037453824

0 references

1 reference

12 May 2018